These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6401747

  • 1. Absence of a suppressive effect of 2-hydroxyestrone on hyperprolactinemia in patients with prolactinomas before and after estradiol administration.
    Lamberts SW, Oosterom R.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):230-3. PubMed ID: 6401747
    [Abstract] [Full Text] [Related]

  • 2. Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
    Schinfeld JS, Tulchinsky D, Schiff I, Fishman J.
    J Clin Endocrinol Metab; 1980 Feb; 50(2):408-10. PubMed ID: 7354124
    [Abstract] [Full Text] [Related]

  • 3. Lack of suppression of increased circulating prolactin by 2-hydroxyestrone.
    Kicovic PM, Franchi F, Luisi M.
    Reproduccion; 1982 Feb; 6(2):113-6. PubMed ID: 7141097
    [Abstract] [Full Text] [Related]

  • 4. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition.
    Nicoletti I, Filipponi P, Fedeli L, Gregorini G, Ambrosi F, Sfrappini M, Santeusanio F, Brunetti P.
    Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763
    [Abstract] [Full Text] [Related]

  • 5. Radioimmunoassay of 2-hydroxyestrone in plasma during the estrous cycle of the rat: interrelationships with estradiol, progesterone, and the gonadotropins.
    Cecchini DJ, Chattoraj SC, Fanous AS, Panda SK, Brennan TF, Edelin KC.
    Endocrinology; 1983 Mar; 112(3):1122-6. PubMed ID: 6401618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB, Nippoldt TB, Kletter GB, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormone ontogeny in the ovine fetus: XIV. The effect of 17 beta-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback.
    Gluckman PD, Marti-Henneberg C, Kaplan SL, Grumbach MM.
    Endocrinology; 1983 May; 112(5):1618-23. PubMed ID: 6403330
    [Abstract] [Full Text] [Related]

  • 11. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
    Schaison G, Mowszowicz I, Cesselin E, Lagoguey M.
    Nouv Presse Med; 1977 Feb 12; 6(6):425-8. PubMed ID: 320558
    [Abstract] [Full Text] [Related]

  • 12. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
    Fonseca AL, Chimelli L, Santos MJ, Santos AA, Violante AH.
    Arq Neuropsiquiatr; 2002 Sep 12; 60(3-A):590-602. PubMed ID: 12244397
    [Abstract] [Full Text] [Related]

  • 13. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
    Baird DT, McNeilly AS, Sawers RS, Sharpe RM.
    J Clin Endocrinol Metab; 1979 Oct 12; 49(4):500-6. PubMed ID: 479342
    [Abstract] [Full Text] [Related]

  • 14. The effect of acutely administered 2-hydroxyestrone on the release of gonadotropins and prolactin before and after estrogen priming in hypogonadal women.
    Adashi EY, Rakoff J, Divers W, Fishman J, Yen SS.
    Life Sci; 1979 Oct 12; 25(24-25):2051-5. PubMed ID: 537468
    [No Abstract] [Full Text] [Related]

  • 15. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC, Hsieh CJ.
    Kaohsiung J Med Sci; 2012 Feb 12; 28(2):94-9. PubMed ID: 22313536
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia.
    Bouchard P, Lagoguey M, Brailly S, Schaison G.
    J Clin Endocrinol Metab; 1985 Feb 12; 60(2):258-62. PubMed ID: 3917455
    [Abstract] [Full Text] [Related]

  • 17. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
    Arafah BM.
    J Clin Endocrinol Metab; 1986 Jun 12; 62(6):1173-9. PubMed ID: 3009521
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC.
    J Clin Endocrinol Metab; 1984 Jun 12; 58(6):1141-7. PubMed ID: 6427260
    [Abstract] [Full Text] [Related]

  • 19. Bone density in amenorrheic women with and without hyperprolactinemia.
    Schlechte JA, Sherman B, Martin R.
    J Clin Endocrinol Metab; 1983 Jun 12; 56(6):1120-3. PubMed ID: 6404918
    [Abstract] [Full Text] [Related]

  • 20. [Changes in plasma 2-hydroxyestrone levels in pubertal females and correlation with sex hormones].
    Kawai K, Hashino M, Ohno H, Yanaihara T, Araki H, Nakayama T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec 12; 36(12):2551-60. PubMed ID: 6440931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.